Product Information

MEGESTROL 625 MG/5 ML SUSP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $1.2995 per ML under NDC 24979004113. Its NADAC has been published 575 times since Nov 18, 2015.

FDA first approved this application on Aug 27, 2014.

The High Outlier badge above means this manufacturer's average price in the Megestrol Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MEGESTROL 625 MG/5 ML SUSP

Megestrol Acetate
$1.2995per ML
High Outlier

Strength

125 mg/mL

NDC

24979004113

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MEGESTROL ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203139

FDA Approved

8/27/2014

On Market Since

3/1/2015

Pharmacological Classes

Progesterone Congeners
Progestin

Price Statistics

The NADAC for MEGESTROL 625 MG/5 ML SUSP has been published 575 times since Nov 18, 2015, and over the history we have for it it has declined 66.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2995 per ML
All-time high$4.0820 (Jan 13, 2016)
All-time low$0.8523 (Jun 19, 2024)
52-week high$1.4403
52-week low$1.1596
Median price$1.7931
Average price$1.9743
Largest weekly change+35.3% (Aug 18, 2021)
Weeks tracked575
Tracking sinceNov 18, 2015

Price History

1W

-8.2%

1M

-9.8%

3M

-6.1%

6M

+6.4%

1Y

+5.3%

3Y

-8.7%

5Y

-28.4%

All

-66.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Megestrol Acetate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEGESTROL 625 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for MEGESTROL 625 MG/5 ML SUSP, manufactured by Upsher-Smith Laboratories LLC, is $1.2995 per ML (NDC 24979004113), effective Nov 18, 2026.

How has the price of MEGESTROL 625 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for MEGESTROL 625 MG/5 ML SUSP has declined 66.1%. It has been tracked across 575 weekly CMS publications since Nov 18, 2015.

What are the highest and lowest recorded NADAC prices for MEGESTROL 625 MG/5 ML SUSP?

Since Nov 18, 2015, the NADAC for MEGESTROL 625 MG/5 ML SUSP has ranged from a low of $0.8523 (Jun 19, 2024) to a high of $4.0820 (Jan 13, 2016), with a median of $1.7931 per ML.

Are there cheaper alternatives to MEGESTROL 625 MG/5 ML SUSP?

No other NADAC-published product currently shares the active ingredient and strength of MEGESTROL 625 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MEGESTROL 625 MG/5 ML SUSP?

MEGESTROL 625 MG/5 ML SUSP (NDC 24979004113) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.